HomeASIAMALAYSIADYSON'S LEGAL BATTLE WITH MALAYSIAN EMPLOYEES REACHES APPEAL STAGE

DYSON’S LEGAL BATTLE WITH MALAYSIAN EMPLOYEES REACHES APPEAL STAGE

Published on

spot_img

The British firm Dyson, a manufacturer of household appliances such as vacuum cleaners and hand dryers, is currently facing allegations from former employees of its Malaysian supplier, ATA IMS. They claim that Dyson has been unjustly enriched due to the unlawful, exploitative, and hazardous conditions present at the factory.

Additionally, it is claimed that ATA has instructed its staff to prepare for labor inspections in a manner that conceals the actual working and living conditions, as well as employed foreign workers without the necessary permits. An appeal hearing is set to take place in the United Kingdom in November 2024.

In October 2022, Dyson initiated legal action against Channel 4, alleging that a news report by the network contained defamatory claims regarding abuse. This report featured interviews with ATA workers who reported experiencing abusive conditions at the factory. By the end of October 2022, it was revealed that the High Court had dismissed Dyson’s libel claim against Channel 4. However, in July 2023, Dyson successfully appealed the dismissal of the libel claim. On 23 August 2024, however, Dyson abruptly discontinued the claim.

The damages claims against Dyson were presented at the High Court in July 2023, where Dyson contended that the case should be adjudicated in Malaysia, disputing the assertion that there is adequate connection to the UK for the case to be heard there. In October 2023, the English High Court decided not to assert jurisdiction over the matter. Nevertheless, the workers were granted the opportunity to appeal this decision, with the appeal hearing set for November 2024.

Latest articles

ALLERGAN BREAST IMPLANT LAWSUITS: KEY INSIGHTS INTO THE GROWING LEGAL BATTLE

In recent years, Allergan, the Ireland-based medical device manufacturer, has found itself at the...

EU SLAPS TEVA WITH €462 MILLION FINE FOR ANTI-COMPETITIVE TACTICS IN MS DRUG MARKET

In a landmark decision, the European Commission fined Teva Pharmaceuticals 462.6 million euros for...

DUTCH COURT DISMISSES SHAREHOLDER CLAIMS AGAINST PETROBRAS

On 30 October 2024, the Rotterdam district court ruled to dismiss claims by the...

COURT OF APPEAL TO RECONSIDER USE OF CPR 19.8 IN LANDMARK DATA PRIVACY CLASS ACTION

The Court of Appeal of England and Wales is reviewing an appeal by Andrew...

More like this

ALLERGAN BREAST IMPLANT LAWSUITS: KEY INSIGHTS INTO THE GROWING LEGAL BATTLE

In recent years, Allergan, the Ireland-based medical device manufacturer, has found itself at the...

EU SLAPS TEVA WITH €462 MILLION FINE FOR ANTI-COMPETITIVE TACTICS IN MS DRUG MARKET

In a landmark decision, the European Commission fined Teva Pharmaceuticals 462.6 million euros for...

DUTCH COURT DISMISSES SHAREHOLDER CLAIMS AGAINST PETROBRAS

On 30 October 2024, the Rotterdam district court ruled to dismiss claims by the...